Introduction
Present uncertainty about the correct treatment of pulmonary embolism (British Medical 7ournal, 1968) derives from absence of a means of predicting, at the time of the acute episode, the chances of death or survival in any given patient. Moreover, not all patients who survive achieve complete resolution of emboli by natural lytic mechanisms or with the aid of anticoagulants (Goodwin et al., 1963) . Embolectomy may be lifesaving, but it is a major procedure with a high mortality. On theoretical grounds, therefore, an alternative therapy is needed that is applicable both to acute massive pulmonary embolism and to patients with embolism of lesser severity in whom embolectomy seems unjustified. It is the purpose of this communication to report the results obtained by infusion of streptokinase in nine patients with pulmonary embolism of differing severity and duration.
Methods
Before treatment all patients were studied by cardiac catheterIzation, conventional techniques being used. Pressure measurements were referred to the mid-chest level. Single plane (anteroposterior) serial pulmonary arteriograms were obtained, contrast medium (Triosil 75 ; sodium metrizoate) being injected in a dose of 1 ml./kg. body weight by means of a pressure injector. The right brachial artery was cannulated with a fine polyethylene tube and samples from pulmonary and brachial arteries were analysed for oxygen saturation by means of a haemoreflector (ZijIstra and Mook, 1962) . Oxygen consumption was measured, expired air being analysed for oxygen and carbon dioxide content with the micro-Scholander technique (Scholander, 1947) . Cardiac output was expressed as I./min./ sq.m. body surface area.
In all but one patient (Case 6) the pulmonary artery catheter was left in position and used for a 36-hour infusion of streptokinase (Kabikinase), usually in a dose of 600,000 i.u. for the first half-hour followed by 100,000 i. right pulmonary artery as well as emboli in distal branches of the left pulmonary artery. There was also collapse/consolidation of the right lower lobe distal to an occluded segmental pulmonary artery. A repeat study 48 hours after starting streptokinase therapy showed almost complete disappearance of the filling defects apart from occlusion of a segmental right lower lobe artery with reduction in volume of the corresponding lung segment. Pulmonary artery pressure was actually higher at this time than at the first study, though there had been a fall in the arteriovenous oxygen difference and total pulmonary resistance and a rise in cardiac index (Fig. 3 ). This patient still had some collapse of the right lower lobe when restudied 18 days after the initial event. At this time the pulmonary artery pressure was normal, as was the haemodynamic response to exercise (Fig. 3) . the total pulmonary resistance had therefore fallen (Fig. 4) . A third study one month later showed that pulmonary artery pressure was now lower though still marginally raised (Fig. 4) Case 4.-Pulmonary arteriography performed less than 12 hours after the acute episode showed filling defects in all the branches of the pulmonary arteries. The arteriographic appearances suggested that not all of the embolism was recent and that there might have been previous thromboembolism involving the lower lobe arteries. Repeat study 65 hours after starting streptokinase showed considerable resolution of the emboli to the upper lobe arteries but again suggested old disease of the lower lobe arteries. At this time the pulmonary artery pressure was still raised, but the arteriovenous oxygen difference had fallen and the cardiac index become normal; 
Minor Recent Pulmonary Emboli
There were two patients in whom pulmonary embolism had occurred six days and 12 hours before study respectively.
Pulmonary arteriography showed involvement of less than half of the major pulmonary arterial branches and these patients were therefore classified as having minor pulmonary emboli. In one patient (Case 5) there was no haemodynamic disturbance, in the other (Case 6) there was pre-existing parenchymal lung disease and pulmonary artery pressure was raised (Fig. 5) (Lancet, 1966; Thomas, 1965) . Although spontaneous resolution of the pulmonary emboli has been shown in man (Fred et al., 1966) and in animals (Allison et al., 1960) , patients undoubtedly exist in whom such resolution does not occur (Goodwin et al., 1963) and Case 9 reported here is just such a patient.
The value of heparin therapy in pulmonary embolism has been emphasized (Barritt and Jordan, 1960) ; however, Tow and Wagner (1967) , using lung scans to determine the rate of recovery in 69 patients with pulmonary emboli treated with anticoagulants, found that of 11 with severe or massive embolism complete recovery could be shown in only one (at the 60th day) and the earliest partial recovery was observed on the eighth day. Moreover, these authors, while confirming complete recovery in many patients, found that even in the group with minimal involvement recovery was complete in only 50 % at the end of one month. Hirsh et al. (1967) reported the case of a patient in whom little arteriographic change was observed after 24 hours' treatment with heparin, but in whom a subsequent 24-hour infusion of streptokinase resulted in a striking improvement. This patient is similar to Case 2 reported here in whom heparin had been given for six days without haemodynamic or angiographic improvement but in whom resolution was complete 48 hours after starting a subsequent 36-hour infusion of streptokinase. While such results suggest that streptokinase therapy may lead to more rapid and complete resolution of pulmonary emboli than occurs with anticoagulants or by natural lytic mechanisms alone, firm conclusions must await a properly controlled trial of such therapy.
Despite the reported successful use of streptokinase in arterial thrombosis as long ago as 1962 (Cot-ton et al., 1962) there have been few reports of its use in pulmonary embolism. Browse and James (1964) reported the cases of four patients with pulmonary embolism who were thought on clinical grounds to have improved with streptokinase, and Hirsh et al. (1967) reported the successful treatment of massive pulmonary embolism in two patients in whom the severity of embolization and the efficacy of treatment was established by pulmonary arteriography. Dickie et al. (1967) reported two cases treated with another fibrinolytic agent, urokinase, in which pulmonary arteriograms showed complete resolution of massive emboli at nine and six days respectively. Hirsh et al. (1968) reported a larger series of 18 patients treated with streptokinase. Both these authors and Dickie and associates conclude that fibrinolytic therapy resulted in a more rapid resolution of emboli than would have been expected from the natural lytic mechanisms alone.
At the present time the place of streptokinase in the treatment of pulmonary embolism has still to be defined. It is likely that streptokinase therapy will be of most benefit in recent massive embolism (Hirsh et al., 1968) , and we report four cases of massive pulmonary embolism in which streptokinase resulted in satisfactory resolution and the patients were thus spared embolectomy. However, it is likely that there will remain a proportion of patients in whom the delay in response associated with streptokinase therapy is unacceptable and in whom embolectomy may be life-saving.
Our experience of streptokinase treatment in patients with pulmonary embolic disease of longer duration has been dis- appointing, and it seems unlikely that streptokinase will play an important part in the treatment of such patients (Hirsh et al., 1968) . Finally, while we obtained rapid resolution of minor recent emboli in two patients it must remain arguable whether any treatment, carrying with it the risk of haemorrhagic complications, is justifiable in such patients.
Introduction
Treatment of patients in coronary care units has been shown to lower the mortality from acute myocardial infarction (Fluck et al., 1967; Lawrie et al., 1967; Lown et al., 1967; Restieaux et al., 1967) . This paper attempts to assess the value of routine cardiac monitoring with E.C.G. oscilloscopes in a hospital ward, without the full facilities of a coronary care unit. The results of this management are compared with those from two series of patients admitted to general hospital medical wards, where monitoring was not routinely used during the period analysed. The severity of infarction was determined to discover whether the three management groups were comparable.
Material and Methods Hospitals
Admissions for acute myocardial infarction to three Leicester hospitals were studied. At Groby Road Hospital, which is a regional cardiac unit, both male and female patients were admitted to the same ward, consisting of cubicles for one or two patients opening on to a long corridor. All patients with myocardial infarction were monitored for the first 48 hours, or longer if necessary. There was no coronary care unit on the ward. Two to four patients, though not always with myocardial infarction, were usually being monitored at any one time. The sisters and staff nurses were acquainted with the normal electrocardiographic (E.C.G.) rhythm pattern; they had experience at the recognition on the monitor of traces showing extrasystoles, bradycardia, heart block, and tachycardia. However, no formal course of instruction on E.C.G. arrhythmia patterns had been given to them. Arrhythmias were actively sought for by medical and nursing staff.
At the other two hospitals-the Leicester General Hospital and the Leicester Royal Infirmary-patients with acute myocardial infarction were admitted to general medical wards and were not routinely monitored. The Leicester Royal Infirmary has an intensive therapy ward which in 1966 cared for drug poisoning (25%), trauma (33%), postoperative patients (13%), myocardial infarction (6%), and other medical conditions (23%). The small proportion of patients with myocardial infarction admitted to intensive therapy ward were either severe cases or relatively young patients, and were usually monitored. Because their number was small-that is, 20 out of 162 myocardial infarction patients-and as no significant features were found on their analysis, they have not been separated from the Leicester Royal Infirmary figures.
All cases of acute myocardial infarction admitted to these hospitals over a 13-month period were analysed. 
